A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

A little less conversation (a little more action) in outcomes-based contracts?

by Mary Cummins, Principal, Deloitte Consulting LLP

I’m recently back from AdvaMed’s annual conference where, as always, I was struck by the deep commitment to bring innovation to patients. But innovation is in the eye of the beholder. When it comes to medtech offerings, there are many stakeholders who decide if an innovation is going to deliver differentiated results, and what value is merited in return.

Read more

In an era of exponentials, health care is on the cusp of a potential major transformation

by Sarah Thomas, Managing Director, Deloitte Center for Health Solutions, Deloitte Services LP

As we look to move the ball forward with health IT, we’re closely watching exponential technologies and their potential power to transform the industry. Exponential technologies have the potential to render the health care sector unrecognizable in a relatively short amount of time. Artificial intelligence (AI), robotics, 3D printing, and synthetic biology all have the ability to potentially dramatically disrupt the systems and processes that have historically defined the health care industry.

Read more

Making progress in integrating social determinants of health into the EHR

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Health care stakeholders have long recognized that factors outside the health care system –the social determinants of health (SDoH) – influence an individual’s health and well-being. Many hospitals, health systems, and health plans are navigating the challenges of effectively linking data related to the SDoH and clinical services to improve health outcomes in the long term.

Read more

Can new investors help medtech refill the new product pipeline?

by Pedro Arboleda, Managing Director, Deloitte Monitor

This week, several of my colleagues and I were at AdvaMed’s annual MedTech Conference where we discussed a wide range of topics, including value-based contracting, cybersecurity, and digital health. Yesterday, I led a panel focused on the decline of early-stage investment in medtech, and its impact on startup activity. During the session, we dove into how dwindling investments in those early phases could put future innovation at risk.

Read more

With medtech margins under pressure, is a push to solutions the answer?

by Yakir Siegal, Partner, Deloitte Consulting LLP

In the early 1990s, competition among personal computer manufacturers intensified as pricing pressure from new entrants made the overall sector less profitable. The companies that thrived were those that positioned themselves as sellers of solutions – rather than merely computer vendors. For those companies, computers became one component in a broad technology solution that was sold to customers.

Read more